LXG.V - LexaGene Holdings Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 578.79M
Enterprise Value 382.08M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)20.47
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-11.17

Trading Information

Stock Price History

Beta (5Y Monthly) 2.41
52-Week Change 353.57%
S&P500 52-Week Change 35.18%
52 Week High 31.0000
52 Week Low 30.4300
50-Day Moving Average 30.8156
200-Day Moving Average 30.7520

Share Statistics

Avg Vol (3 month) 3145.29k
Avg Vol (10 day) 3109.28k
Shares Outstanding 585.69M
Float 83.2M
% Held by Insiders 115.54%
% Held by Institutions 10.40%
Shares Short (Jun. 14, 2020) 4185.04k
Short Ratio (Jun. 14, 2020) 42.22
Short % of Float (Jun. 14, 2020) 4N/A
Short % of Shares Outstanding (Jun. 14, 2020) 40.21%
Shares Short (prior month May 14, 2020) 4197.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Feb. 27, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Feb. 28, 2020
Most Recent Quarter (mrq)Feb. 28, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-121.90%
Return on Equity (ttm)-286.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.35M
Net Income Avi to Common (ttm)-7.5M
Diluted EPS (ttm)-0.0980
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.19M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)1.92M
Total Debt/Equity (mrq)49.71
Current Ratio (mrq)6.57
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-5.41M
Levered Free Cash Flow (ttm)-2.77M